USO DE MEDICAMENTOS E PROLONGAMENTO DO INTERVALO QTc EM UMA UNIDADE DE TERAPIA INTENSIVA ADULTO
Long QT syndrome; Intensive Care Units; Side Effects and Adverse Reactions Related to Medicines.
Objective: The objective of this study was to investigate the prevalence of QTc prolongation in critically ill patients, their risk factors and degree of association with the medications administered. Method: An observational, prospective, cross sectional conducted in a Intensive Care Unit (ICU) general, who conducted the analysis of QT interval by electrocardiogram (ECG) at admission to the unit and the research of drugs previously used for admission. Results: The prevalence of 33.9% was detected, and 13.3% had QTc> 500 ms. The age (OR 1.017, p = 0.00), temperature (OR 0.812, p = 0.01), diabetes (OR 1.440, p = 0.04), elective surgery (OR 1.852, p = 0.00), potassium (OR 0.828, p = 0.05) and magnesium (OR 1.514, p = 0.02) were shown to be risk factors for QTc prolongation. The amiodarone medication (OR 2.434, p = 0.02) and haloperidol (OR 3.333, p = 0.02) were associated with increased risk of QTc prolongation. The drugs cefazolin, cefepime, midazolam, nitroglycerin, norepinephrine, sufentanil and protamine were identified as new QTc prolongation inducers. In 69.9% of patients with long QT prescription drugs were also increased risk, being furosemide, ondansetron, pantoprazole metoclopramide and amiodarone the most frequently used. Conclusions: There was a significant prevalence of QTc prolongation in critical patients, who often receive drugs already related to QTc prolongation during their stay in the unit. Hypermagnesemia and exposure to a surgical procedure were identified as new risk factors for the occurrence of QTc prolongation. Other drugs not further described by AZCERT were identified as potential inducers QTc prolongation.